Clarithromycin Plus CTd Regimen for Patients With Newly Diagnosed Multiple Myeloma

Clinical trial NCT02248428 · UNKNOWN

Trial details

NCT number: NCT02248428
Sponsor: Jinling Hospital, China
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2012-04-01
Primary completion: 2019-09-01
Enrollment: 130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.